U.S. Stocks Seen Outperforming Europe, HSBC Says

On April 29, 2026 HSBC moved to upgrade U.S. equities versus European peers, framing the call around earnings momentum, household resilience and balance-sheet reallocation (MarketWatch/HSBC, Apr 29, 2026). The bank’s note — cited by MarketWatch — argues that a combination of positive EPS revisions, heavier corporate buyback activity and investor positioning leave U.S. stocks structurally better placed to outperform. HSBC quantified part of the case by pointing to recent 3-month EPS revision trends (HSBC note, Apr 2026) and to sustained buyback flows that have supported headline returns. For institutional investors, the call re-opens the active debate on allocation between the S&P 500-dominated beta and Europe’s cyclically exposed, value-heavy opportunity set. This article dissects the data underpinning HSBC’s recommendation, contrasts it with recent market performance, and outlines scenarios in which the call is more — or less — likely to play out.

Context

HSBC’s upgrade on Apr 29, 2026 (reported by MarketWatch) is the latest large-bank assessment to favor U.S. equities after a sustained period of outperformance for American markets. The backdrop: the S&P 500 has been the dominant component of global indices for years; MSCI weights the U.S. at roughly 63% of MSCI World versus roughly 15% for Europe as of Dec 31, 2025 (MSCI, Dec 2025). That structural weighting amplifies any U.S.-led macro or earnings surprise, and it is central to HSBC’s allocation reasoning. The bank’s note frames the U.S. case not only in terms of absolute fundamentals but relative momentum — essentially a positioning call that a larger share of active managers remain underweight U.S. exposure.

HSBC’s timing is notable given market dispersion: year-to-date performance through late April showed a substantial gap, with the S&P 500 outperforming the Stoxx 600 by several percentage points (Bloomberg, Apr 28, 2026). Currency dynamics also matter; EUR/USD and GBP/USD moves since January 2026 have trimmed euro-area reported earnings in dollar terms, amplifying the U.S. appearance of stronger growth when measured for dollar-based global investors. HSBC explicitly lists consumer resilience in the United States — as measured by retail sales and services consumption remaining above pre-COVID trend lines — as a pillar supporting its upgrade (HSBC note, Apr 2026).

Contextually, the upgrade follows a stretch of active repositioning: flows into U.S.-centric ETFs and mutual funds have been positive relative to Europe for eight of the past twelve months (EPFR/Bloomberg, Apr 2026). That said, Europe’s headline valuations remain lower on consensus metrics, a factor that invites debate about mean reversion and upside optionality should macro data surprise positively. Investors therefore face a trade-off between momentum-driven overweighting of U.S. equities and valuation-driven contrarian allocations to European markets.

Data Deep Dive

HSBC’s argument rests on a handful of empiric claims. First, the bank highlights recent EPS revision differentials: HSBC’s model shows 12-month forward EPS revisions for the U.S. rising by roughly +3.5% over the prior three months versus a modest -0.5% for European consensus over the same window (HSBC note, Apr 29, 2026). Second, HSBC points to corporate balance-sheet activity: S&P Dow Jones Indices reports that S&P 500-level buybacks remained substantial in 2025, roughly in the order of $1.0 trillion for the year (S&P Dow Jones Indices, Dec 2025), providing direct support to aggregate EPS and index-level demand. Those two data points underpin the tactical and strategic recommendation.

Third, HSBC cites positioning: mutual fund and ETF positioning data show a net underweight to U.S. equities among global active managers, creating scope for a catch-up flow if earnings momentum persists (Bloomberg/EPFR, Apr 2026). Fourth, macro indicators — notably U.S. services PMI and retail spending — have surprised modestly to the upside in early 2026, supporting the idea that consumer resilience can prop up top-line growth for domestic-facing companies (U.S. Census Bureau and ISM, Q1 2026 releases). Each of these items is explicit in HSBC’s note and is reflected in the MarketWatch summary of Apr 29, 2026.

A comparative lens clarifies the magnitude: at the end of 2025 the median forward P/E for the S&P 500 was near 18–20x consensus earnings, versus the Stoxx 600 at roughly 11–13x — a substantial valuation gap (Bloomberg/MSCI, Dec 2025). That gap implies differing sensitivities to earnings momentum; a +3–4% surprise to U.S. EPS revisions can materially alter expected returns, whereas Europe’s lower starting multiple limits upside absent a stronger macro reacceleration. Investors must reconcile those different return profiles within portfolio construction frameworks and risk budgets.

Sector Implications

If HSBC’s thesis plays out, the immediate beneficiaries should be large-cap U.S. sectors that combine resilient end-demand with outsized buyback activity and heavy analyst coverage. Technology and consumer discretionary — which together account for a significant share of S&P 500 market-cap — have seen the bulk of positive EPS revisions in early 2026 (Bloomberg consensus, Apr 2026). Banks and industrials could also benefit from improved cyclical confidence in the U.S. if the consumer maintains spending power and investment picks up.

Conversely, defensive segments and commodity-linked names in Europe could underperform on relative returns even if they deliver absolute gains. The Stoxx 600’s exposure to energy and materials can provide episodic upside when global growth surprises, but HSBC’s note asserts that current macro signals favor U.S. domestic demand. From an active-sector perspective, managers who can tilt toward U.S. cyclical exposures while hedging currency and geopolitical risks stand to capture the relative premium HSBC describes.

At the company level, the buyback channel is critical. Firms that returned capital aggressively in 2024–25 (top quintile of buyback intensity) have materially outperformed peers over rolling 12-month windows, and HSBC points to that historical pattern as evidence buybacks can be a dependable support for EPS per share (S&P Dow Jones Indices, Dec 2025). Institutional investors should therefore assess treasury activity and capex outlooks as part of any tactical overweight to U.S. exposures.

Risk Assessment

HSBC’s recommendation is not without risks. Valuation remains the clearest counterargument: the U.S. premium versus Europe implies that even modest shocks to growth or a re-rating event could produce more significant downside in the S&P 500 than in cheaper European indices. A 10–15% downside to U.S. EPS revisions would compress multiples and could erase the yield of the buyback cushion over a 6–12 month horizon. Currency swings — particularly a rapid EUR appreciation or USD weakness — would mechanically boost European earnings in dollar terms and could reverse the relative story.

Macroeconomic and policy risks also matter. The U.S. Federal Reserve’s stance and forward guidance on policy tightening remain data-dependent; a surprise hawkish pivot in response to sticky inflation could increase real rates and pressure growth multiple stocks. On the other hand, Europe faces idiosyncratic political and energy-supply risks that could derail a durable cyclical rebound. Each of these outcomes maps into scenario analyses that should be integrated into any position-sizing decision.

Finally, positioning dynamics can be a double-edged sword. The current underweight to U.S. assets noted by HSBC creates upside potential, but it also implies that flows are path-dependent; if negative shocks trigger de-risking, those same positioning imbalances can exacerbate outflows from risk assets. Institutional investors need to balance conviction with liquidity and drawdown tolerance when adjusting cross-border allocations.

Outlook

Short-to-medium-term, HSBC’s overweight call to U.S. equities rests on continued positive EPS revisions, stable consumer demand and persistent buyback flows. If those elements remain intact through Q3 2026, the relative performance gap between the S&P 500 and major European indices is likely to persist. Conversely, a European macro surprise — for instance, a faster-than-expected acceleration in manufacturing activity or a substantial fiscal impulse from major EU economies — could close the gap rapidly given Europe’s lower base valuations.

From a portfolio construction standpoint, investors should treat the upgrade as a relative-value signal rather than a mandate to pursue concentrated U.S. exposure. Risk-managed overweighting — for instance, using derivatives to hedge key exposures or implementing phased allocations as data confirms the EPS trajectory — can preserve upside while limiting downside. Active managers with a fundamental edge in earnings forecasting and capital-allocation analysis are best positioned to exploit the differential HSBC highlights.

Fazen Markets Perspective

Fazen Markets views HSBC’s upgrade as a data-driven, momentum-leaning recommendation that is timely but not dispositive. The contrarian lens is that Europe’s lower valuations and greater sensitivity to cyclical surprises make it the higher optionality bet in scenarios where inflation moderates and manufacturing reaccelerates. Put differently, HSBC’s call is asymmetric: it identifies a plausible path for U.S. outperformance predicated on continued EPS upgrades, but it does not fully price the tail risk that a Euro-area growth surprise or a USD reversal could produce rapid mean reversion.

We also highlight a nuance often under-discussed in public notes: the mechanical elasticity of index returns to buybacks varies by sector and company size. Large-cap tech buybacks have different marginal impacts on free-float and turnover than buybacks in mid-cap industrials. Consequently, a headline U.S. overweight executed via mega-cap ETFs will have a different risk-return profile than a selection of mid-cap, buyback-intensive firms. Tactical allocation decisions should therefore be instrument-aware.

Finally, considering cross-asset indicators — currency forwards, real yields and commodity futures — can materially change the return calculus. For clients seeking to express an overweight to the U.S. thesis while limiting single-market concentration, Fazen Markets recommends scenarios and stress tests over binary bets. For readers wishing to review our broader views on cross-market allocation and macro, see our equities and macro research pages for further context: equities and macro.

FAQ

Q: How material are buybacks to U.S. index returns? A: Historically, buybacks have been a non-trivial contributor. S&P Dow Jones reported buybacks near $1.0tn in 2025 (S&P Dow Jones Indices, Dec 2025), and firms in the top quintile of buyback intensity outperformed peers on a 12-month rolling basis. The impact varies by free-float and sector, meaning index-level effects are aggregate and not uniformly distributed.

Q: Could a stronger euro flip the relative performance? A: Yes. A rapid EUR appreciation versus USD would translate into higher reported euro-area revenues for multinational firms and improve dollar-denominated returns for Europe in international portfolios. Currency is a high-leverage channel and has historically reversed relative performance gaps within quarters.

Q: What historical precedent exists for Europe outperforming after an extended U.S. run? A: In past cycles (notably 2003–2006 and 2009–2011), Europe outperformed following synchronized global recoveries when cyclical sectors and commodity prices rose. Those episodes required multi-quarter improvements in manufacturing and capex; absent that, valuation gaps tend to persist.

Bottom Line

HSBC’s Apr 29, 2026 upgrade of U.S. equities rests on measurable EPS momentum, sizable buyback flows and an underweight positioning backdrop; those factors support a tactical U.S. overweight but do not eliminate valuation and currency risks. Investors should treat the call as a conditional, data-dependent tilt and apply scenario-based sizing and hedging.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.